NovaBay Pharmaceuticals I... (NBY)
AMEX: NBY
· Real-Time Price · USD
0.60
0.02 (3.45%)
At close: May 16, 2025, 3:59 PM
0.59
-1.19%
After-hours: May 16, 2025, 05:05 PM EDT
3.45% (1D)
| Bid | 0.59 |
| Market Cap | 3.47M |
| Revenue (ttm) | 9.78M |
| Net Income (ttm) | -7.22M |
| EPS (ttm) | -2.53 |
| PE Ratio (ttm) | -0.24 |
| Forward PE | -1.58 |
| Analyst | Buy |
| Ask | 0.63 |
| Volume | 17,020 |
| Avg. Volume (20D) | 60,287 |
| Open | 0.59 |
| Previous Close | 0.58 |
| Day's Range | 0.58 - 0.60 |
| 52-Week Range | 0.36 - 9.10 |
| Beta | 0.42 |
Analyst Forecast
According to 0 analyst ratings, the average rating for NBY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
NovaBay Pharmaceuticals Inc. is scheduled to release its earnings on May 27, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
+18.24%
NovaBay Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
7 months ago
+48.92%
NovaBay Pharmaceuticals shares are trading higher after the company announced it reached a definitive deal to sell its Avenova assets for $9.5 million.
